A Phase III Trial of Z-338 in Paediatric Patients With Functional Dyspepsia | MicrobiomeTrials← Back to trialsNCT04526119
A Phase III Trial of Z-338 in Paediatric Patients With Functional Dyspepsia
CompletedPHASE3INTERVENTIONAL
Trial Details
Start: 2021-02-22Est. Completion: 2026-03-02
Enrollment target: 55 participants Locations- Zeria Investigative Site, Matsumoto, Nagano, Japan
Other microbiome trials you might be interested in
Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that substantially affects quality of li…
Istanbul, Turkey (Türkiye)Completed Nov 25, 2021
Solid Tumors
The purpose of this study is to evaluate the efficacy and safety of standard chemotherapy with or without INCB161734 in …
Birmingham, United StatesEst. completion Sep 15, 2028